FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors

Shoko Kitade, Ichiro Onoyama, Hiroaki Kobayashi, Hiroshi Yagi, Sachiko Yoshida, Masaya Kato, Ryosuke Tsunematsu, Kazuo Asanoma, Kenzo Sonoda, Norio Wake, Kenichiro Hata, Keiichi I. Nakayama, Kiyoko Kato

研究成果: ジャーナルへの寄稿記事

15 引用 (Scopus)

抄録

FBXW7 is a ubiquitin ligase that mediates ubiquitylation of oncoproteins, such as c-Myc, cyclin E, Notch and c-Jun. FBXW7 is a known tumor-suppressor gene, and mutations in FBXW7 have been reported in various human malignancies. In this study, we examined the sequences of the FBXW7 and p53 genes in 57 ovarian cancer clinical samples. Interestingly, we found no FBXW7 mutations associated with amino acid changes. We also investigated FBXW7 expression levels in 126 epithelial ovarian tumors. FBXW7 expression was negatively correlated with the malignant potential of ovarian tumors. That is to say, FBXW7 expression levels in ovarian cancer samples were significantly lower than those in borderline and benign tumors (P < 0.01). FBXW7 expression levels in serous carcinoma samples were the lowest among four major histological subtypes. In addition, p53-mutated ovarian cancer samples showed significantly lower levels of FBXW7 expression compared with p53 wild-type cancer samples (P < 0.001). DNA methylation arrays and bisulfite PCR sequencing experiments revealed that 5′-upstream regions of FBXW7 gene in p53-mutated samples were significantly higher methylated compared with those in p53 wild-type samples (P < 0.01). This data indicates that p53 mutations might suppress FBXW7 expression through DNA hypermethylation of FBXW7 5′-upstream regions. Thus, FBXW7 expression was downregulated in ovarian cancers, and was associated with p53 mutations and the DNA methylation status of the 5′-upstream regions of FBXW7.

元の言語英語
ページ(範囲)1399-1405
ページ数7
ジャーナルCancer Science
107
発行部数10
DOI
出版物ステータス出版済み - 10 1 2016

Fingerprint

Ovarian Neoplasms
Phenotype
p53 Genes
DNA Methylation
Neoplasms
Mutation
Genetic Suppression
Cyclin E
Ubiquitination
Oncogene Proteins
Ligases
Ubiquitin
Oligonucleotide Array Sequence Analysis
Tumor Suppressor Genes
Down-Regulation
Carcinoma
Amino Acids
Polymerase Chain Reaction
DNA

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors. / Kitade, Shoko; Onoyama, Ichiro; Kobayashi, Hiroaki; Yagi, Hiroshi; Yoshida, Sachiko; Kato, Masaya; Tsunematsu, Ryosuke; Asanoma, Kazuo; Sonoda, Kenzo; Wake, Norio; Hata, Kenichiro; Nakayama, Keiichi I.; Kato, Kiyoko.

:: Cancer Science, 巻 107, 番号 10, 01.10.2016, p. 1399-1405.

研究成果: ジャーナルへの寄稿記事

Kitade, S, Onoyama, I, Kobayashi, H, Yagi, H, Yoshida, S, Kato, M, Tsunematsu, R, Asanoma, K, Sonoda, K, Wake, N, Hata, K, Nakayama, KI & Kato, K 2016, 'FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors', Cancer Science, 巻. 107, 番号 10, pp. 1399-1405. https://doi.org/10.1111/cas.13026
Kitade, Shoko ; Onoyama, Ichiro ; Kobayashi, Hiroaki ; Yagi, Hiroshi ; Yoshida, Sachiko ; Kato, Masaya ; Tsunematsu, Ryosuke ; Asanoma, Kazuo ; Sonoda, Kenzo ; Wake, Norio ; Hata, Kenichiro ; Nakayama, Keiichi I. ; Kato, Kiyoko. / FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors. :: Cancer Science. 2016 ; 巻 107, 番号 10. pp. 1399-1405.
@article{4bc181e2d0bf40d884e7457a608405db,
title = "FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors",
abstract = "FBXW7 is a ubiquitin ligase that mediates ubiquitylation of oncoproteins, such as c-Myc, cyclin E, Notch and c-Jun. FBXW7 is a known tumor-suppressor gene, and mutations in FBXW7 have been reported in various human malignancies. In this study, we examined the sequences of the FBXW7 and p53 genes in 57 ovarian cancer clinical samples. Interestingly, we found no FBXW7 mutations associated with amino acid changes. We also investigated FBXW7 expression levels in 126 epithelial ovarian tumors. FBXW7 expression was negatively correlated with the malignant potential of ovarian tumors. That is to say, FBXW7 expression levels in ovarian cancer samples were significantly lower than those in borderline and benign tumors (P < 0.01). FBXW7 expression levels in serous carcinoma samples were the lowest among four major histological subtypes. In addition, p53-mutated ovarian cancer samples showed significantly lower levels of FBXW7 expression compared with p53 wild-type cancer samples (P < 0.001). DNA methylation arrays and bisulfite PCR sequencing experiments revealed that 5′-upstream regions of FBXW7 gene in p53-mutated samples were significantly higher methylated compared with those in p53 wild-type samples (P < 0.01). This data indicates that p53 mutations might suppress FBXW7 expression through DNA hypermethylation of FBXW7 5′-upstream regions. Thus, FBXW7 expression was downregulated in ovarian cancers, and was associated with p53 mutations and the DNA methylation status of the 5′-upstream regions of FBXW7.",
author = "Shoko Kitade and Ichiro Onoyama and Hiroaki Kobayashi and Hiroshi Yagi and Sachiko Yoshida and Masaya Kato and Ryosuke Tsunematsu and Kazuo Asanoma and Kenzo Sonoda and Norio Wake and Kenichiro Hata and Nakayama, {Keiichi I.} and Kiyoko Kato",
year = "2016",
month = "10",
day = "1",
doi = "10.1111/cas.13026",
language = "English",
volume = "107",
pages = "1399--1405",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors

AU - Kitade, Shoko

AU - Onoyama, Ichiro

AU - Kobayashi, Hiroaki

AU - Yagi, Hiroshi

AU - Yoshida, Sachiko

AU - Kato, Masaya

AU - Tsunematsu, Ryosuke

AU - Asanoma, Kazuo

AU - Sonoda, Kenzo

AU - Wake, Norio

AU - Hata, Kenichiro

AU - Nakayama, Keiichi I.

AU - Kato, Kiyoko

PY - 2016/10/1

Y1 - 2016/10/1

N2 - FBXW7 is a ubiquitin ligase that mediates ubiquitylation of oncoproteins, such as c-Myc, cyclin E, Notch and c-Jun. FBXW7 is a known tumor-suppressor gene, and mutations in FBXW7 have been reported in various human malignancies. In this study, we examined the sequences of the FBXW7 and p53 genes in 57 ovarian cancer clinical samples. Interestingly, we found no FBXW7 mutations associated with amino acid changes. We also investigated FBXW7 expression levels in 126 epithelial ovarian tumors. FBXW7 expression was negatively correlated with the malignant potential of ovarian tumors. That is to say, FBXW7 expression levels in ovarian cancer samples were significantly lower than those in borderline and benign tumors (P < 0.01). FBXW7 expression levels in serous carcinoma samples were the lowest among four major histological subtypes. In addition, p53-mutated ovarian cancer samples showed significantly lower levels of FBXW7 expression compared with p53 wild-type cancer samples (P < 0.001). DNA methylation arrays and bisulfite PCR sequencing experiments revealed that 5′-upstream regions of FBXW7 gene in p53-mutated samples were significantly higher methylated compared with those in p53 wild-type samples (P < 0.01). This data indicates that p53 mutations might suppress FBXW7 expression through DNA hypermethylation of FBXW7 5′-upstream regions. Thus, FBXW7 expression was downregulated in ovarian cancers, and was associated with p53 mutations and the DNA methylation status of the 5′-upstream regions of FBXW7.

AB - FBXW7 is a ubiquitin ligase that mediates ubiquitylation of oncoproteins, such as c-Myc, cyclin E, Notch and c-Jun. FBXW7 is a known tumor-suppressor gene, and mutations in FBXW7 have been reported in various human malignancies. In this study, we examined the sequences of the FBXW7 and p53 genes in 57 ovarian cancer clinical samples. Interestingly, we found no FBXW7 mutations associated with amino acid changes. We also investigated FBXW7 expression levels in 126 epithelial ovarian tumors. FBXW7 expression was negatively correlated with the malignant potential of ovarian tumors. That is to say, FBXW7 expression levels in ovarian cancer samples were significantly lower than those in borderline and benign tumors (P < 0.01). FBXW7 expression levels in serous carcinoma samples were the lowest among four major histological subtypes. In addition, p53-mutated ovarian cancer samples showed significantly lower levels of FBXW7 expression compared with p53 wild-type cancer samples (P < 0.001). DNA methylation arrays and bisulfite PCR sequencing experiments revealed that 5′-upstream regions of FBXW7 gene in p53-mutated samples were significantly higher methylated compared with those in p53 wild-type samples (P < 0.01). This data indicates that p53 mutations might suppress FBXW7 expression through DNA hypermethylation of FBXW7 5′-upstream regions. Thus, FBXW7 expression was downregulated in ovarian cancers, and was associated with p53 mutations and the DNA methylation status of the 5′-upstream regions of FBXW7.

UR - http://www.scopus.com/inward/record.url?scp=84992457670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992457670&partnerID=8YFLogxK

U2 - 10.1111/cas.13026

DO - 10.1111/cas.13026

M3 - Article

C2 - 27486687

AN - SCOPUS:84992457670

VL - 107

SP - 1399

EP - 1405

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 10

ER -